InhibRx News and Activities

Presence

Inhibrx develops protein-based therapies for serious diseases. Its main products and services include drug discovery and clinical-stage biologic medicines for patients, healthcare providers, and pharmaceutical partners.

InhibRx products and services overview:

  • Biologic therapies
  • Cancer treatments
  • Rare disease therapies
  • Drug discovery
  • Clinical development

Revenue: ~$8 million

Employees: 250

Headquarters: La Jolla, United States (USA)


InhibRx is one of the...

InhibRx is a company listed under the stock ticker INBX (US).

Executives

View the org chart displaying its 19 main executives

Most searched biographies at InhibRx

Create your alert
to follow the executive moves at InhibRx.

Biotechnology

InhibRx has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by InhibRx
Social media about InhibRx

Get in Touch

Call InhibRx at +1 858...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board